New headache for Haleon
Aug 19, 2022
2 minutes
SK’s listing of its consumer-products arm Haleon is rapidly “turning into a textbook case of how not to do a spin-off”, says Aimee Donnellan on Breakingviews. The hived-off company, in which Pfizer also owned a stake, floated last month. But last week Haleon’s shares plunged owing
You’re reading a preview, subscribe to read more.
Start your free 30 days